Summit Therapeutics (SMMT) Debt Ratio (2016 - 2024)
Historic Debt Ratio for Summit Therapeutics (SMMT) over the last 6 years, with Q1 2024 value amounting to 0.57.
- Summit Therapeutics' Debt Ratio rose 4418.8% to 0.57 in Q1 2024 from the same period last year, while for Mar 2024 it was 0.57, marking a year-over-year increase of 4418.8%. This contributed to the annual value of 0.49 for FY2023, which is 3382.57% down from last year.
- As of Q1 2024, Summit Therapeutics' Debt Ratio stood at 0.57, which was up 4418.8% from 0.49 recorded in Q4 2023.
- In the past 5 years, Summit Therapeutics' Debt Ratio ranged from a high of 0.74 in Q4 2022 and a low of 0.0 during Q1 2020
- Its 4-year average for Debt Ratio is 0.39, with a median of 0.41 in 2023.
- Examining YoY changes over the last 5 years, Summit Therapeutics' Debt Ratio showed a top increase of 8237.38% in 2023 and a maximum decrease of 3382.57% in 2023.
- Over the past 4 years, Summit Therapeutics' Debt Ratio (Quarter) stood at 0.0 in 2020, then soared by 66922.33% to 0.74 in 2022, then tumbled by 33.83% to 0.49 in 2023, then increased by 14.8% to 0.57 in 2024.
- Its last three reported values are 0.57 in Q1 2024, 0.49 for Q4 2023, and 0.42 during Q2 2023.